Skip to main content

Table 3 Median differences of estimated absorbed dose in normal tissues and bone metastases between 2D and 3D method, and between hybrid and 3D method

From: Comparison of different methods for post-therapeutic dosimetry in [177Lu]Lu-PSMA-617 radioligand therapy

 

Median of differences

2D vs. 3D

Median of differences

HYBRID vs. 3D

[Gy/GBq]

[%]

p-value

[Gy/GBq]

[%]

p-value

Parotid gland

−0.080

−9.8

0.003

0.002

0.3

0.685

Submandibular gland

−0.003

−0.4

0.950

0.014

1.9

0.440

Kidneys

−0.059

−10.9

0.005

−0.021

−4.0

0.060

Liver

−0.004

−3.5

0.093

0.003

2.9

0.100

Bone metastases

−0.074

−4.4

<0.0001

−0.117

−7.0

<0.0001